Physician profile
Raymond K Ryan
NPI 1154498152
$854.52
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $762 · 2023: $64.33 · 2024: $28.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $92.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $92.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $233.83 | 2022-2023 | Ubrelvy |
| Biohaven Pharmaceutical Holding Company LTD. | $127.40 | 2022 | |
| Ucb, INC. | $50.59 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.93 | 2022 | |
| Neurelis, INC. | $35.46 | 2022 | |
| Novartis Pharmaceuticals Corporation | $34.72 | 2022-2023 | |
| Scilex Pharmaceuticals INC. | $34.22 | 2022 | |
| Emd Serono, INC. | $28.13 | 2024 | |
| Sunovion Pharmaceuticals INC. | $26.73 | 2022 | |
| Corium, LLC | $23.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $20.16 | 2022 | |
| Acorda Therapeutics, INC | $19.85 | 2022 | |
| Avion Pharmaceuticals | $18.27 | 2023 | Dhivy |
| Idorsia Pharmaceuticals US INC | $18.26 | 2022 | |
| Jazz Pharmaceuticals INC. | $18.24 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $16.60 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.81 | 2022 | |
| Acadia Pharmaceuticals INC | $15.78 | 2022 | |
| Pfizer INC. | $14.75 | 2022 | |
| Grifols USA, LLC | $13.54 | 2022 | |
| Supernus Pharmaceuticals, INC. | $12.62 | 2022 | |
| Lundbeck LLC | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.